-
Johnson & Johnson Seeks Centralization of 103 New Jersey Talcum Powder Cases
Posted By Golomb & Honik, P.C.
||
30-Sep-2015
Attorneys for the pharmaceutical giant, Johnson & Johnson, are asking that the 103 lawsuits claiming the company’s talcum powder products caused ovarian cancer be consolidated into multicounty litigation. The application on behalf of Johnson & Johnson seeks to have the individual lawsuits centralized in Atlantic County before Superior Court Judge Nelson Johnson. J & J asserts ...
Continue Reading
-
Testosterone Gel Lawsuits on Fast Track Trial
Posted By Golomb & Honik, P.C.
||
5-Sep-2015
Nearly 2,000 federal testosterone injury lawsuits have been filed after a significant number of men suffered serious harm following the use of a low testosterone drug such as Axiron, Testim and AndroGel. After an MDL was established in the Northern District of Illinois in June 2014 to centralize the cases, more and more men have come forward to join that MDL. This type of consolidation and ...
Continue Reading
-
Potential Dangers of Invokana
Posted By Golomb & Honik, P.C.
||
19-Aug-2015
What is Invokana? Invokana is in a new class of medication called SGLT2 inhibitors used to treat Type II diabetes. Phase III clinical trials of the drug showed patients taking Invokana reduced their overall body weight and systolic blood pressure and improved their blood glucose control. Invokana reduces blood glucose via the kidneys, increasing glucose loss in the urine. Normally when glucose is ...
Continue Reading
-
10 Things to Know about Xarelto Lawsuits
Posted By Golomb & Honik, P.C.
||
14-Aug-2015
Xarelto was approved by the FDA in 2009 for the prevention of blood clots in those undergoing knee or hip surgery. In 2011, Xarelto gained approval to treat those with atrial fibrillation and for stroke prevention in patients. Xarelto has also been approved to treat and reduce recurring blood clots. Johnson & Johnson, the maker of Xarelto, has spent millions of dollars touting the benefits of ...
Continue Reading
-
Early Trial Selection for Androgel Lawsuits
Posted By Golomb & Honik, P.C.
||
9-Aug-2015
AndroGel testosterone supplement lawsuits continue to progress in an Illinois U.S. District Court overseen by Judge Matthew Kennelly. The coordination of more than 1,500 lawsuits is involved in this MDL. The MDL was established a little more than a year ago with an eye toward streamlining early trial proceedings. Judge Kennelly denied bifurcation requests to separate the liability question from ...
Continue Reading
-
Recent Testim Lawsuit Highlights Dangers of Testosterone Drug
Posted By Golomb & Honik, P.C.
||
5-Aug-2015
A lawsuit was filed several months ago on behalf of a sixty-two-year-old after he suffered a stroke and heart attack from taking the dangerous testosterone drug, Testim. The Maryland resident used Testim from August 2012 to July 2013. He suffered a stroke in April 2013, and then a heart attack in July 2013. The lawsuit alleges both cardiac events are directly related to his use of Testim, and that ...
Continue Reading
-
Pfizer Executives Warned about the Link Between Zoloft and Birth Defects
Posted By Golomb & Honik, P.C.
||
29-Jul-2015
Just last year one of Pfizer’s own scientists warned top executives about a possible link between birth defects and the anti-depressant drug Zoloft. At that time, changes were recommended regarding changes to the safety warnings on the drug. The document clearly shows Pfizer was warned of Zoloft’s potential risks and would seem to complicate the more than 1,000 lawsuits brought by ...
Continue Reading
-
Eye Hemorrhaging and Stomach Bleeds Tied to Xarelto
Posted By Golomb & Honik, P.C.
||
28-Jul-2015
Two recent studies have linked Xarelto, a blood-thinning drug manufactured by Johnson & Johnson, to an increased risk of stomach bleeds and eye hemorrhaging. In the first study, two doctors found a significant number of patients in their 70’s and 80’s who switched from Warfarin to Xarelto suffered a bleed between the lens of the eye and the retina. These cases were reported in the ...
Continue Reading
-
New Study Shows Xarelto Doubles Risk of Gastrointestinal Bleeding
Posted By Golomb & Honik, P.C.
||
22-Jul-2015
Xarelto is a newer blood thinner that has been on the market since 2011. Its primary function is to reduce the risk of blood clots in patients who have Deep Vein Thrombosis, pulmonary embolism, or have undergone a knee or hip replacement. Unlike older blood thinners, such as Heparin or Coumadin, patients taking Xarelto do not need to undergo regular blood testing and there are fewer known drug and ...
Continue Reading
-
Johnson & Johnson Pays Millions to Settle Risperdal Lawsuit
Posted By Golomb & Honik, P.C.
||
8-Jul-2015
The state of Arkansas will receive $7.8 million from Johnson & Johnson to settle claims by the state that J & J illegally marketed the antipsychotic drug, Risperdal. The original $1.2 billion award against J & J was thrown out, and the settlement which is less than one percent of that fine was eventually agreed on. The Arkansas Supreme Court overturned the first verdict based on their ...
Continue Reading
-
Zofran Linked to Birth Defects by Four Studies
Posted By Golomb & Honik
||
11-May-2015
The drug Zofran (Ondansetron) has been linked by at least four studies to an increased risk of birth defects. Zofran was approved by the FDA in 1991 only for the treatment of nausea experienced by chemotherapy and radiation patients, as well as for patients who experienced nausea following a surgical procedure. Zofran officials, however, touted the drug to doctors as a cure for severe morning ...
Continue Reading
-
Zofran Lawsuit Charges GlaxcoSmithKline with Failure to Warn
Posted By Golomb & Honik, P.C.
||
15-Apr-2015
A recent lawsuit filed in the U.S. District Court of the District of Massachusetts charges GlaxcoSmithKline, the manufacturer of the drug Zofran, with failure to warn pregnant patients of the potential risks of birth defects when Zofran is used in the first trimester. The victim and her family is asking for compensatory and punitive damages due to birth defects. The child, born in 2000, has ...
Continue Reading
-
Alleged FDA and J&J Risperdal Cover Up Exposed
Posted By Golomb & Honik
||
24-Mar-2015
Earlier this year, the U.S. Food and Drug Administration was sued in Pennsylvania federal court. The suit claims that the FDA barred a law firm from turning over confidential Risperdal documents, which were obtained through the discovery process. This directly resulted in the denial of a citizen petition asking that Johnson & Johnson publicize documents relating to the dangers of the ...
Continue Reading
-
Daiichi Sankyo Agrees to Pay $39 Million to Settle Benicar Kickback Allegations
Posted By Golomb & Honik
||
24-Mar-2015
2015 did not start very well for pharmaceutical company Daiichi Sankyo. In January 2015, the company agreed to pay the United States and state Medicaid programs $39 million after allegations surfaced that they paid physicians kickbacks to prescribe drugs, such as Azor, Benicar, Tribenzor, and Welchol. This is in direct violation of the False Claims Act and the Anti-Kickback Statute. The ...
Continue Reading
-
Testosterone Lawsuits Move Forward
Posted By Golomb & Honik, P.C.
||
21-Mar-2015
Plaintiffs who have suffered heart attack, stroke or death, due to the use of testosterone supplements, will finally see their cases moving forward. U.S. District Judge Matthew F. Kennelly recently met with attorneys arguing the testosterone cases in order to discuss future case management strategies. The testosterone cases have been consolidated in a federal multidistrict litigation in the U.S. ...
Continue Reading
-
Xarelto Lawsuit MDL Created in Pennsylvania
Posted By Golomb & Honik, P.C.
||
20-Mar-2015
Despite the fact that some Xarelto lawsuits have been coordinated in Federal Court in New Orleans, while others have been coordinated in State Court in Philadelphia, manufacturers Bayer and Johnson & Johnson continue to push the FDA for Xarelto approvals. There are hundreds of lawsuits on file with plaintiffs claiming adverse health issues and even death as a result of taking Xarelto. In light ...
Continue Reading
-
Public Citizen Petitions FDA to Recall Fungal Drug Ketoconazole
Posted By Golomb & Honik, P.C.
||
14-Mar-2015
The consumer advocacy group Public Citizen has recently petitioned the FDA to recall the fungal medication ketoconazole due to concerns over an increased risk of liver damage. In their statement to the FDA, Public Citizen made the following claims: The risk of liver damage far outweighs the "questionable" benefits of this drug The FDA sent an internal memo in 2013 that classified the ...
Continue Reading
-
Granuflo Lawsuits Rising
Posted By Golomb & Honik
||
1-Mar-2015
As of February 2015, more than 2,575 lawsuits are pending against Fresenius in the District of Massachusetts federally-filed GranuFlo MDL. The lawsuits claim Fresenius knew-or should have known-about the increased risk of death and serious injury associated with GranuFlo, and that those risks were concealed and misrepresented by Fresenius Medical Care. Lawsuits seek punitive damages in addition to ...
Continue Reading
-
Patients Taking Xarelto Don't Know There is NO Antidote
Posted By Golomb & Honik, P.C.
||
28-Jan-2015
Those patients taking the blood thinner, Xarelto, still don’t know that they are at an increased risk for bleeding to death. That’s because Xarelto manufacturers have kept that secret pretty well hidden. Now, lawsuits across the country are cropping up, after patients taking Xarelto have bled to death or experienced serious injury. Unlike traditional blood thinners, Coumadin or ...
Continue Reading
-
FDA Delays Issuing New Generic Drug Label Rule
Posted By Golomb & Honik
||
31-Dec-2014
A new proposed rule that will allow generic drug makers to update their own safety warnings on labels has been delayed until the fall of 2015. The new rule has been labeled as “controversial” because it would give the makers of generic drugs the ability independently update safety warnings. This is currently something that only brand-name drug makers are allowed to do prior to ...
Continue Reading
-
Xarelto Lawsuits Seek MDL Status
Posted By Golomb & Honik, P.C.
||
19-Dec-2014
Hearings to determine whether or not to consolidate Xarelto Bleedout Lawsuits are scheduled for December 2014. Court documents indicate that multidistrict litigation status for Re: Xarelto Products Liability Litigation has been proposed by six plaintiffs who are also lobbying to have an additional 21 Xarelto Bleedout Lawsuits consolidated in MDL status for the Southern District of Illinois. ...
Continue Reading
-
First Benicar Wrongful Death Case Filed
Posted By Golomb & Honik
||
6-Nov-2014
In the past year, Benicar has been the focus of numerous lawsuits. Each lawsuit alleged that the dangerous drug caused victims to develop sprue-like enteropathy and other severe GI complications. Now, however, a different lawsuit is being filed against the manufacturers of Benicar-a wrongful death lawsuit. This is the first lawsuit that alleges the dangerous drug Benicar directly caused or ...
Continue Reading
-
Naproxin Bottles Recalled Due to Packaging Error
Posted By Golomb & Honik, P.C.
||
5-Nov-2014
If you recently purchased Assured brand naproxen sodium at Dollar Tree or through the Dollar Tree website, you may have inadvertently purchased ibuprofen. Due to a packaging error, 11,640 boxes were mistakenly filled with the wrong softgel pills. The mistake and recall was announced via a press release issued by the U.S. Food and Drug Administration (FDA) on October 20, 2014. The press release ...
Continue Reading
-
The Dangers of Testim
Posted By Golomb & Honik
||
24-Oct-2014
Auxilium Pharmaceuticals received FDA approval on October 31, 2002 for Testim, a testosterone supplement administered via transdermal patches or gel applied to the upper arms and shoulders on a daily basis. Testim was only approved for use among men with very low testosterone levels or those who have stopped producing the hormone altogether; however, huge numbers of men across the nation are being ...
Continue Reading
-
FDA Cracks Down on Children's Cold Medicine Labels
Posted By Golomb & Honik
||
15-Oct-2014
When your child is sick, you want to trust that the medicine you give them is safe and effective. But when pharmaceutical companies fail to adequately label their products, the consequences can be severe. The United States Food and Drug Administration (FDA) recently released draft guidelines intended to make children's cold medicines safer. The new guidelines specifically address ...
Continue Reading
36 results found. Viewing page 1 of 2.
Go to page